REG - Credit Suisse Cap. Willis Towers Watson - Form 38.5b - Willis Towers Watson plc

Willis Towers WatsonAnnouncement

14/06/2021 11:30

RNS Number : 8093B
  
Credit Suisse Capital LLC
  
14 June 2021
  
 

Ap27
 
 
FORM 38.5(b)
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
 
 
1.          KEY INFORMATION
 



Name of exempt principal trader


 Credit Suisse Capital LLC




Company dealt in


Willis Towers Watson Plc




Class of relevant security to which the dealings being disclosed relate (Note 1)


Ordinary




Date of dealing


11th June 2021













 
2.          INTERESTS AND SHORT POSITIONS
 
(a)         Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)
 







Long


Short








Number






(%)


Number






(%)




(1) Relevant securities


209,568         0.15


 183,700       0.20




(2) Derivatives (other than options)












(3) Options and agreements to purchase/sell












Total


209,568         0.15


 183,700       0.20












 
 
(b)         Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)
 



Class of relevant security: Swap


Long


Short








Number






(%)


Number






(%)




(1) Relevant securities












(2) Derivatives (other than options)


0                       0


199,778       0.14




(3) Options and agreements to purchase/sell












Total


0                       0


199,778       0.14












Ap28
 
 
3.       DEALINGS (Note 3)
 
(a)      Purchases and sales
 



Purchase/sale


Number of relevant securities


Price per unit (USD)




B


2


258.14




B


2


258.14




B


2


257.5




S


2


258.14




S


2


257.5



 
(b)      Derivatives transactions (other than options transactions)
 



Product name,
e.g. CFD


Nature of transaction
(Note 5)


Number of relevant securities
(Note 6)


Price per unit
(Note 4) (USD)





















 
(c)      Options transactions in respect of existing relevant securities
 
 
(i)       Writing, selling, purchasing or varying
 



Product name,
e.g. call option


Writing, selling, purchasing, varying etc.


Number of securities to which the option relates (Note 7)


Exercise price


Type, e.g. American, European etc.


Expiry date


Option money paid/received per unit (Note 4)

































 
 
(ii)      Exercising
 



Product name,
e.g. call option


Number of securities


Exercise price per unit (Note 4)

















 
 
(d)      Other dealings (including transactions in respect of new securities) (Note 3)
 



Nature of transaction
(Note 7)


Details


Price per unit
(if applicable) (Note 4)

















Ap29
 
4.       OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
 
 
 
 
 
 
 
 
Is a Supplemental Form 38.5(b) attached? (Note 8)                    NO
 
 



Date of disclosure


14th June 2021
 




Contact name


Anthony Allen / Paul MacDonald




Telephone number


0207 888 5416 / 8548




Name of offeree/offeror with which connected


Aon plc




Nature of connection (Note 9)


Advisor to Aon plc



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ISEBZLFFFQLLBBZ